Logo
Logo


ISSN: 0300-9041
ISSNe: 2594-2034


Indizada en: SciELO, Índice Médico Latinoamericano, LILACS, Medline
Editada por la Federación Mexicana de Colegios de Obstetricia, y Ginecologia AC
Fundada por la Asociación Mexicana de Ginecología y Obstetricia en 1945
 

INFORMACIÓN EXCLUSIVA PARA LOS PROFESIONALES DE LA SALUD


Periodicidad: continua
Abreviatura: Ginecol Obstet Mex
ISSN: 0300-9041
ISSNe: 2594-2034
Indizada en: Scimago, Índice Médico Latinoamericano, Lilacs, Medline, Science Citation Index, Ulrich, Ebsco.

Derrame pleural unilateral como única manifestación del síndrome de hiperestimulación ovárica en el contexto de un tratamiento de fecundación in vitro

Unilateral pleural effusion like sole manifestation of the ovarian hyperstimulation syndrome in the context of a treatmnet of in vitro fertilization

Ginecol Obstet Mex. 2021; 89 (4): 343-349.

https://doi.org/10.24245/gom.v89i4.4585

Isabel Castillo, Juan Carlos García-Lozano, Julia Guisado-Fernández, Cristina Rosales, Inés Ruiz-Fernández, Guillermo Antiñolo-Gil

Departamento de Genética, Reproducción y Medicina Materno fetal, Hospital Universitario Virgen del Rocío, España.


Corrrespondencia:
Debe citarse como:

Castillo I, García-Lozano JC, Guisado-Fernández J, Rosales C, Ruiz-Fernández I, Antiñolo-Gil G. Derrame pleural unilateral como única manifestación del síndrome de hiperestimulación ovárica en el contexto de un tratamiento de fecundación in vitro. Ginecol Obstet Mex. 2021; 89 (4): 343-349. https://doi.org/10.24245/gom.v89i4.4585

Resumen

ANTECEDENTES: El síndrome de hiperestimulación ovárica es una complicación de los tratamientos de fertilidad, sobre todo de la fecundación in vitro, que se caracteriza por el aumento de la permeabilidad vascular que provoca la acumulación de líquido extravascular, en particular en el abdomen. El derrame pleural es una forma de manifestación infrecuente, que suele asociarse con ascitis y casos severos de síndrome de hiperestimulación ovárica. Solo existen casos documentados en los que el derrame pleural unilateral es aislado e imprevisible.

CASO CLÍNICO: Paciente de 41 años a quien se indicó un ciclo de fertilización in vitro. Acudió al servicio de Urgencias debido a dolor costal derecho y disnea, asociados con tos y saturación de oxígeno del 94%. A la auscultación se advirtió: ausencia de murmullo vesicular en el hemitórax derecho. La ecografía transtorácica objetivó un derrame pleural derecho que ameritó la evacuación de 1300 cc. La ecografía abdominal mostró escaso líquido libre y los ovarios de aspecto hiperestimulado. El laboratorio reportó: leucocitosis de 19.41 x 10^3/µL, hematocrito del 38% y funciones hepática y renal normales. Se trató con albúmina intravenosa y equilibrio hídrico estricto. Fue necesario practicar dos toracocentesis evacuadoras más para el control de los síntomas. En la actualidad cursa el tercer trimestre de un embarazo gemelar.

CONCLUSIÓN: Ante el incremento de los tratamientos de fertilidad es importante la sospecha de este cuadro en pacientes que consulten por síntomas respiratorios, incluso en ausencia de síntomas abdominales para su atención en unidades especializadas.

PALABRAS CLAVE: Síndrome de hiperestimulación ovárica; fertilización in vitro; permeabilidad vascular; derrame pleural; acumulación extravascular de líquido; ascitis.

Abstract

BACKGROUND: Ovarian hyperstimulation syndrome is a complication of fertility treatments such as in vitro fertilization, characterized by increased vascular permeability causing an accumulation of fluid in the extravascular space, mainly in the abdomen. Pleural effusion is a rare presentation form, usually associated with ascites and severe cases of SHO; there are very few documented cases in the literature in which unilateral pleural effusion occurs in isolation, and its presentation is frequently unpredictable.

CLINICAL CASE: 41-year-old patient who underwent an IVF cycle and consulted the emergency room for right pleuritic pain and dyspnea, associated with cough, presenting an oxygen saturation of 94%. Auscultation showed absence of vesicular murmur in the right hemithorax. A transthoracic ultrasound was performed in the emergency department, showing a right pleural effusion, evacuating 1300cc. Abdominal ultrasound showed little free fluid and ovaries with a hyperstimulated appearance. Laboratory tests showed a leukocytosis of 19.41 x 10 ^ 3 / µL, a hematocrit of 38%, and normal liver and kidney functions. She was treated with intravenous albumin and strict fluid balance. She required two more evacuating thoracenteses to control symptoms. She is currently in the third trimester of a twin gestation.

CONCLUSION: Given the increased use of fertility treatments, it is important to suspect this condition in patients with a history, who consult for respiratory symptoms even in the absence of abdominal symptoms for proper management by specialized units.

KEYWORDS: Ovarian hyperstimulation syndrome; In vitro fertilization; Vascular permeability; Abdomen pleural effusion; Ascites.

    1. Blumenfeld Z. The Ovarian Hyperstimulation Syndrome [Internet]. 1st ed. Vol. 107, Vitamins and Hormones. Elsevier Inc.; 2018;423-51. http://dx.doi.org/10.1016/bs.vh.2018.01.018.
    2. Irani M, Robles A, Gunnala V, Chung P, Rosenwaks Z. Unilateral pleural effusion as the sole clinical presentation of severe ovarian hyperstimulation syndrome: a systematic review. Gynecol Endocrinol 2018; 34 (2): 92-9. https://doi.org/10.1080/09513590.2017.1390738.
    3. Friedler S, Rachstein A, Bukovsky I, Ron-El R, Raziel A. Unilateral hydrothorax as a sole and recurrent manifestation of ovarian hyperstimulation syndrome following in-vitro fertilization. Hum Reprod. 1998; 13 (4): 859-61. doi. 10.1093/humrep/13.4.859.
    4. de Diego P, Suárez L, Guasch E. Síndrome de hiperestimulación ovárica. Rev Esp Anestesiol Reanim. 1995; 42 (1): 37.
    5. Shields R, Vollenhoven B, Ahuja K, Talmor A. Ovarian hyperstimulation syndrome: A case control study investigating risk factors. Aust New Zeal J Obstet Gynaecol 2016; 56 (6): 624-7. http://doi.wiley.com/10.1111/ajo.12515
    6. Elchalal U, Schenker JG. The pathophysiology of ovarian hyperstimulation syndrome - Views and ideas. Hum Reprod. 1997; 12 (6): 1129-37. doi. 10.1093/humrep/12.6.1129.
    7. Rinaldi ML, Spirtos NJ. Chest tube drainage of pleural effusion correcting abdominal ascites in a patient with severe ovarian hyperstimulation syndrome: A case report. Fertil Steril 1995; 63 (5): 1114-17. http://dx.doi.org/10.1016/S0015-0282(16)57558-X.
    8. Cortés JL, Ligero G, Sánchez L, Nieto A, Bueno C, Montes R, et al. Aplicabilidad en preembriones crioconservados donados para investigación con células madre. Asebir 2008; 14 (1): 6-13. https://revista.asebir.com/riterios-de-valoracion-morfologicos-de-oocitos-preembriones-tempranos-y-blastocistos-humanos-propuestos-por-asebir/.
    9. Sopa N, Larsen EC, Andersen AN. A case with severe endometriosis, ovarian hyperstimulation syndrome, and isolated unilateral pleural effusion after IVF. Case Rep Obstet Gynecol. 2017; 2017: 1-4. doi. 10.1155/2017/8243204
    10. van der Linden M, Buckingham K, Farquhar C, Kremer JAM, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev. 2015; 2015( 7). https://doi.org/10.1002/14651858.CD009154.pub3
    11. Mathur RS, Akande AV, Keay SD, Hunt LP, Jenkins JM. Distinction between early and late ovarian hyperstimulation syndrome. Fertil Steril 2000; 73 (5): 901-7. https://linkinghub.elsevier.com/retrieve/pii/S0015028200004921
    12. Lee TH, Liu CH, Huang CC, Wu YL, Shih YT, Ho NN, et al. Serum anti-müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles. Obstet Gynecol Surv. 2008; 63 (6): 378-9. doi. 10.1097/01.ogx.0000314815.40384.a4
    13. Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology ( Review ). Summary of Findings for the Main Comparison. Cochrane Database Syst Rev. 2016; (CD001750.). https://doi.org/10.1002/14651858.CD001750.pub4.
    14. Nastri CO, Ferriani RA, Rocha IA, Martins WP. Ovarian hyperstimulation syndrome: Pathophysiology and prevention. J Assist Reprod Genet. 2010; 27 (2–3): 121-8. doi. 10.1007/s10815-010-9387-6.
    15. Mümüşoğlu S, Tanaçan A, Turan V, Bozdağ G. Ovarian hyperstimulation syndrome presenting with isolated unilateral right-side hydrothorax: A report of two cases and systematic review of the literature. Turk Jinekoloji ve Obstet Dern Derg. 2020; 17 (1): 65-72. doi. 10.4274/tjod.galenos.2019.89656
    16. Mullin CM, Fino ME, Reh A, Grifo JA, Licciardi F. Symptomatic Isolated Pleural Effusion as an Atypical Presentation of Ovarian Hyperstimulation Syndrome. Case Rep Obstet Gynecol. 2011; 2011: 1-4. doi.10.1155/2011/967849.
    17. Levin MF, Kaplan BR, Hutton LC. Thoracic manifestations of ovarian hyperstimulation syndrome. Can Assoc Radiol J = J l’Association Can des Radiol. 1995; 46 (1): 23-6.
    18. Khairy M, El-Toukhy T, Emovon E, Khalaf Y. Hydrothorax as the sole manifestation of ovarian hyperstimulation syndrome: Unusual case and literature review. Reprod Biomed Online 2007; 14 (6): 715-7. http://dx.doi.org/10.1016/S1472-6483(10)60673-6.
    19. Vrtačnik-Bokal E, Meden-Vrtovec H, Osredkar J, Verdenik I. Follicular fluid renin concentration in patients with polycystic ovaries treated with gonadotrophins in an in vitro fertilisation programme. Clin Chem Lab Med. 2003; 41 (5): 663-7. doi. 10.1515/CCLM.2003.100.
    20. Delbaere A, Bergmann PJM, Gervy-Decoster C, Camus M, De Maertelaer V, Englert Y. Prorenin and active renin concentrations in plasma and ascites during severe ovarian hyperstimulation syndrome. Hum Reprod. 1997; 12 (2): 236-40. doi. 10.1093/humrep/12.2.236.
    21. Johnston R, Loo R V. Hepatic hydrothorax; studies to determine the source of the fluid and report of thirteen cases. Ann Intern Med. 1964; 61 (38): 385-401. https://doi.org/10.7326/0003-4819-61-3-385.
    22. Huang PM, Chang YL, Yang CY, Lee YC. The morphology of diaphragmatic defects in hepatic hydrothorax: Thoracoscopic finding. J Thorac Cardiovasc Surg. 2005; 130 (1): 141-5. doi. 10.1016/j.jtcvs.2004.08.051.

Comentarios